-
1
-
-
0015221083
-
Tumor angiogenesis: Therapeutic implications
-
10.1056/NEJM197108122850711 1:STN:280:DyaE38%2FgvVCqsQ%3D%3D 4938153
-
J Folkman 1971 Tumor angiogenesis: therapeutic implications N Engl J Med 285 1182 1186 10.1056/NEJM197108122850711 1:STN:280:DyaE38%2FgvVCqsQ%3D%3D 4938153
-
(1971)
N Engl J Med
, vol.285
, pp. 1182-1186
-
-
Folkman, J.1
-
2
-
-
23444460271
-
Antiangiogenic therapy for cancer: Current and emerging concepts
-
RK Jain 2005 Antiangiogenic therapy for cancer: current and emerging concepts Oncology (Williston Park) 19 4 Suppl 3 7 16
-
(2005)
Oncology (Williston Park)
, vol.19
, Issue.4 SUPPL. 3
, pp. 7-16
-
-
Jain, R.K.1
-
3
-
-
0015546597
-
Tumor angiogenesis: Iris neovascularization at a distance from experimental intraocular tumors
-
4692862
-
MA Gimbrone SB Leapman RS Cotran J Folkman 1973 Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors J Natl Cancer Inst 50 1 219 228 4692862
-
(1973)
J Natl Cancer Inst
, vol.50
, Issue.1
, pp. 219-228
-
-
Gimbrone, M.A.1
Leapman, S.B.2
Cotran, R.S.3
Folkman, J.4
-
4
-
-
0026083903
-
Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
-
10.1056/NEJM199101033240101 1:STN:280:DyaK3M%2FnsVWquw%3D%3D 1701519
-
N Weidner J Semple W Welch J Folkman 1991 Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma N Engl J Med 324 1 1 8 10.1056/NEJM199101033240101 1:STN:280:DyaK3M%2FnsVWquw%3D%3D 1701519
-
(1991)
N Engl J Med
, vol.324
, Issue.1
, pp. 1-8
-
-
Weidner, N.1
Semple, J.2
Welch, W.3
Folkman, J.4
-
5
-
-
0026089377
-
Microvascular architecture in a mammary carcinoma: Branching patterns and vessel dimensions
-
1:STN:280:DyaK3M7gsFKntg%3D%3D 1988088
-
J Less T Skalak E Sevick R Jain 1991 Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions Cancer Res 51 1 265 273 1:STN:280:DyaK3M7gsFKntg%3D%3D 1988088
-
(1991)
Cancer Res
, vol.51
, Issue.1
, pp. 265-273
-
-
Less, J.1
Skalak, T.2
Sevick, E.3
Jain, R.4
-
6
-
-
0033839080
-
Openings between defective endothelial cells explain tumor vessel leakiness
-
1:STN:280:DC%2BD3c3hs1Kntg%3D%3D 10751361
-
H Hashizume P Baluk S Morikawa J McLean G Thurston S Roberge, et al. 2000 Openings between defective endothelial cells explain tumor vessel leakiness Am J Pathol 156 4 1363 1380 1:STN:280:DC%2BD3c3hs1Kntg%3D%3D 10751361
-
(2000)
Am J Pathol
, vol.156
, Issue.4
, pp. 1363-1380
-
-
Hashizume, H.1
Baluk, P.2
Morikawa, S.3
McLean, J.4
Thurston, G.5
Roberge, S.6
-
7
-
-
0023909330
-
Determinants of tumor blood flow: A review
-
1:STN:280:DyaL1c7psVeisQ%3D%3D 3282647
-
RK Jain 1988 Determinants of tumor blood flow: a review Cancer Res 48 10 2641 2658 1:STN:280:DyaL1c7psVeisQ%3D%3D 3282647
-
(1988)
Cancer Res
, vol.48
, Issue.10
, pp. 2641-2658
-
-
Jain, R.K.1
-
8
-
-
33645702901
-
Imaging vascular physiology to monitor cancer treatment
-
10.1016/j.critrevonc.2005.10.006 16387510
-
GR Laking C West DL Buckley J Matthews PM Price 2006 Imaging vascular physiology to monitor cancer treatment Crit Rev Oncol Hematol 58 2 95 113 10.1016/j.critrevonc.2005.10.006 16387510
-
(2006)
Crit Rev Oncol Hematol
, vol.58
, Issue.2
, pp. 95-113
-
-
Laking, G.R.1
West, C.2
Buckley, D.L.3
Matthews, J.4
Price, P.M.5
-
9
-
-
70350545808
-
Molecular imaging of hypoxia with radiolabelled agents
-
10.1007/s00259-009-1195-9 1:CAS:528:DC%2BD1MXht1WhtLrI 19565239
-
G Mees R Dierckx C Vangestel C Van de Wiele 2009 Molecular imaging of hypoxia with radiolabelled agents Eur J Nucl Med Mol Imaging 36 10 1674 1686 10.1007/s00259-009-1195-9 1:CAS:528:DC%2BD1MXht1WhtLrI 19565239
-
(2009)
Eur J Nucl Med Mol Imaging
, vol.36
, Issue.10
, pp. 1674-1686
-
-
Mees, G.1
Dierckx, R.2
Vangestel, C.3
Van De Wiele, C.4
-
14
-
-
20844437405
-
Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; Primary chemotherapy as Biomarker Discovery Laboratory
-
10.1007/s10549-004-2044-y 1:CAS:528:DC%2BD2MXhtVamsrs%3D 15692762
-
K Miller S Soule C Calley R Emerson G Hutchins K Kopecky, et al. 2005 Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory Breast Cancer Res Treat 89 2 187 197 10.1007/s10549-004-2044-y 1:CAS:528:DC%2BD2MXhtVamsrs%3D 15692762
-
(2005)
Breast Cancer Res Treat
, vol.89
, Issue.2
, pp. 187-197
-
-
Miller, K.1
Soule, S.2
Calley, C.3
Emerson, R.4
Hutchins, G.5
Kopecky, K.6
-
15
-
-
10744225601
-
SU5416 plus interferon alpha in advanced renal cell carcinoma: A phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition
-
1:CAS:528:DC%2BD3sXosVGjsb4%3D 14581348
-
PN Lara DI Quinn K Margolin FJ Meyers J Longmate P Frankel, et al. 2003 SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition Clin Cancer Res 9 13 4772 4781 1:CAS:528: DC%2BD3sXosVGjsb4%3D 14581348
-
(2003)
Clin Cancer Res
, vol.9
, Issue.13
, pp. 4772-4781
-
-
Lara, P.N.1
Quinn, D.I.2
Margolin, K.3
Meyers, F.J.4
Longmate, J.5
Frankel, P.6
-
16
-
-
0042622316
-
Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane
-
10.1038/sj.bjc.6601105 1:CAS:528:DC%2BD3sXlsVaktbc%3D 12865914
-
H Anderson J Yap P Wells M Miller D Propper P Price, et al. 2003 Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane Br J Cancer 89 2 262 267 10.1038/sj.bjc.6601105 1:CAS:528:DC%2BD3sXlsVaktbc%3D 12865914
-
(2003)
Br J Cancer
, vol.89
, Issue.2
, pp. 262-267
-
-
Anderson, H.1
Yap, J.2
Wells, P.3
Miller, M.4
Propper, D.5
Price, P.6
-
17
-
-
0036453656
-
Decreased tumor blood flow as measured by positron emission tomography in cancer patients treated with interleukin-1 and carboplatin on a phase i trial
-
10.1007/s00280-002-0517-4 1:CAS:528:DC%2BD38XovFyrt7k%3D 12451469
-
T Logan F Jadali M Egorin M Mintun D Sashin W Gooding, et al. 2002 Decreased tumor blood flow as measured by positron emission tomography in cancer patients treated with interleukin-1 and carboplatin on a phase I trial Cancer Chemother Pharmacol 50 6 433 444 10.1007/s00280-002-0517-4 1:CAS:528: DC%2BD38XovFyrt7k%3D 12451469
-
(2002)
Cancer Chemother Pharmacol
, vol.50
, Issue.6
, pp. 433-444
-
-
Logan, T.1
Jadali, F.2
Egorin, M.3
Mintun, M.4
Sashin, D.5
Gooding, W.6
-
18
-
-
0037106384
-
Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin
-
10.1200/JCO.2002.05.102 1:CAS:528:DC%2BD38XntVyns7o%3D 12228200
-
R Herbst N Mullani D Davis K Hess D McConkey C Charnsangavej, et al. 2002 Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin J Clin Oncol 20 18 3804 3814 10.1200/JCO.2002.05.102 1:CAS:528:DC%2BD38XntVyns7o%3D 12228200
-
(2002)
J Clin Oncol
, vol.20
, Issue.18
, pp. 3804-3814
-
-
Herbst, R.1
Mullani, N.2
Davis, D.3
Hess, K.4
McConkey, D.5
Charnsangavej, C.6
-
20
-
-
0034666257
-
Correlation between angiographically assessed vascularity and blood flow in hepatic metastases in patients with colorectal carcinoma
-
10.1002/1097-0142(20000915)89 :6<1236::AID-CNCR7>3.0.CO;2-K 1:STN:280:DC%2BD3cvltFahug%3D%3D 11002218
-
A Yamaguchi H Taniguchi S Kunishima T Koh H Yamagishi 2000 Correlation between angiographically assessed vascularity and blood flow in hepatic metastases in patients with colorectal carcinoma Cancer 89 6 1236 1244 10.1002/1097-0142(20000915)89:6<1236::AID-CNCR7>3.0.CO;2-K 1:STN:280:DC%2BD3cvltFahug%3D%3D 11002218
-
(2000)
Cancer
, vol.89
, Issue.6
, pp. 1236-1244
-
-
Yamaguchi, A.1
Taniguchi, H.2
Kunishima, S.3
Koh, T.4
Yamagishi, H.5
-
21
-
-
0035990761
-
Identification of angiogenesis in primary breast carcinoma according to the image analysis
-
10.1023/A:1016150213253 1:CAS:528:DC%2BD38XltV2jtrs%3D 12186372
-
S-W Kim S-S Park S-J Ahn K-W Chung WK Moon J-G Im, et al. 2002 Identification of angiogenesis in primary breast carcinoma according to the image analysis Breast Cancer Res Treat 74 2 121 129 10.1023/A:1016150213253 1:CAS:528:DC%2BD38XltV2jtrs%3D 12186372
-
(2002)
Breast Cancer Res Treat
, vol.74
, Issue.2
, pp. 121-129
-
-
Kim, S.-W.1
Park, S.-S.2
Ahn, S.-J.3
Chung, K.-W.4
Moon, W.K.5
Im, J.-G.6
-
23
-
-
24044503731
-
Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography
-
10.1111/j.1464-410X.2005.05681.x 16104907
-
N Lawrentschuk AMT Poon SS Foo LGJ Putra C Murone ID Davis, et al. 2005 Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography BJU Int 96 4 540 546 10.1111/j.1464-410X.2005. 05681.x 16104907
-
(2005)
BJU Int
, vol.96
, Issue.4
, pp. 540-546
-
-
Lawrentschuk, N.1
Poon, A.M.T.2
Foo, S.S.3
Putra, L.G.J.4
Murone, C.5
Davis, I.D.6
-
24
-
-
54949157918
-
Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: A pilot study
-
10.1007/s10350-008-9420-3 18682881
-
DW Dietz F Dehdashti PW Grigsby RS Malyapa RJ Myerson J Picus, et al. 2008 Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study Dis Colon Rectum 51 11 1641 1648 10.1007/s10350-008-9420-3 18682881
-
(2008)
Dis Colon Rectum
, vol.51
, Issue.11
, pp. 1641-1648
-
-
Dietz, D.W.1
Dehdashti, F.2
Grigsby, P.W.3
Malyapa, R.S.4
Myerson, R.J.5
Picus, J.6
-
25
-
-
0035863303
-
Phase i trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer
-
1:CAS:528:DC%2BD3MXhtVektLg%3D 11208848
-
D Rischin L Peters R Hicks P Hughes R Fisher R Hart, et al. 2001 Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer J Clin Oncol 19 2 535 542 1:CAS:528: DC%2BD3MXhtVektLg%3D 11208848
-
(2001)
J Clin Oncol
, vol.19
, Issue.2
, pp. 535-542
-
-
Rischin, D.1
Peters, L.2
Hicks, R.3
Hughes, P.4
Fisher, R.5
Hart, R.6
-
26
-
-
15844368087
-
Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy
-
15695784
-
S-M Eschmann F Paulsen M Reimold H Dittmann S Welz G Reischl, et al. 2005 Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy J Nucl Med 46 2 253 260 15695784
-
(2005)
J Nucl Med
, vol.46
, Issue.2
, pp. 253-260
-
-
Eschmann, S.-M.1
Paulsen, F.2
Reimold, M.3
Dittmann, H.4
Welz, S.5
Reischl, G.6
-
27
-
-
33845495384
-
Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in nonsmall cell lung cancer
-
10.1097/01.coc.0000242345.71582.e0 17149002
-
L Li J Yu L Xing K Ma H Zhu H Guo, et al. 2006 Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in nonsmall cell lung cancer Am J Clin Oncol 29 6 628 633 10.1097/01.coc.0000242345.71582.e0 17149002
-
(2006)
Am J Clin Oncol
, vol.29
, Issue.6
, pp. 628-633
-
-
Li, L.1
Yu, J.2
Xing, L.3
Ma, K.4
Zhu, H.5
Guo, H.6
-
28
-
-
12444290525
-
18F]FDG PET imaging in soft tissue sarcomas: Correlation of hypoxia, metabolism and VEGF expression
-
1:CAS:528:DC%2BD3sXjsF2ksbk%3D 12632200
-
18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression Eur J Nucl Med Mol Imaging 30 5 695 704 1:CAS:528:DC%2BD3sXjsF2ksbk%3D 12632200
-
(2003)
Eur J Nucl Med Mol Imaging
, vol.30
, Issue.5
, pp. 695-704
-
-
Rajendran, J.G.1
Wilson, D.C.2
Conrad, E.U.3
Peterson, L.M.4
Bruckner, J.D.5
Rasey, J.S.6
-
30
-
-
28544444512
-
Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent
-
10.1007/s00259-005-1880-2 16133382
-
RJ Hicks D Rischin R Fisher D Binns AM Scott LJ Peters 2005 Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent Eur J Nucl Med Mol Imaging 32 12 1384 1391 10.1007/s00259-005-1880-2 16133382
-
(2005)
Eur J Nucl Med Mol Imaging
, vol.32
, Issue.12
, pp. 1384-1391
-
-
Hicks, R.J.1
Rischin, D.2
Fisher, R.3
Binns, D.4
Scott, A.M.5
Peters, L.J.6
-
31
-
-
33646241326
-
18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: A feasibility study
-
10.1186/1471-2407-6-51 16515707
-
18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study BMC Cancer 6 51 10.1186/1471-2407-6-51 16515707
-
(2006)
BMC Cancer
, vol.6
, pp. 51
-
-
Gagel, B.1
Reinartz, P.2
Demirel, C.3
Kaiser, H.J.4
Zimny, M.5
Piroth, M.6
-
32
-
-
33646454133
-
18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of Trans-Tasman Radiation Oncology Group Study 98.02
-
10.1200/JCO.2005.05.2878 16648512
-
18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02 J Clin Oncol 24 13 2098 2104 10.1200/JCO.2005.05.2878 16648512
-
(2006)
J Clin Oncol
, vol.24
, Issue.13
, pp. 2098-2104
-
-
Rischin, D.1
Hicks, R.J.2
Fisher, R.3
Binns, D.4
Corry, J.5
Porceddu, S.6
-
33
-
-
0036373462
-
Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21
-
10.1007/s00259-002-0888-0 1:CAS:528:DC%2BD38Xmt1Cgur0%3D 12192567
-
FJP Hoebers HLK Janssen AV Olmos D Sprong AD Nunn AJM Balm, et al. 2002 Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21 Eur J Nucl Med Mol Imaging 29 9 1206 1211 10.1007/s00259-002-0888-0 1:CAS:528:DC%2BD38Xmt1Cgur0%3D 12192567
-
(2002)
Eur J Nucl Med Mol Imaging
, vol.29
, Issue.9
, pp. 1206-1211
-
-
Hoebers, F.J.P.1
Janssen, H.L.K.2
Olmos, A.V.3
Sprong, D.4
Nunn, A.D.5
Balm, A.J.M.6
-
35
-
-
13844305874
-
Assessment of Tc-99 m sestamibi tumor tissue uptake under the influence of increased arterial oxygen saturation
-
10.1016/j.nucmedbio.2004.12.003 1:CAS:528:DC%2BD2MXhsV2jsLk%3D 15721762
-
TF Cermik G Altiay MF Firat ON Hatipoglu S Berkarda 2005 Assessment of Tc-99 m sestamibi tumor tissue uptake under the influence of increased arterial oxygen saturation Nucl Med Biol 32 2 165 170 10.1016/j.nucmedbio.2004.12.003 1:CAS:528:DC%2BD2MXhsV2jsLk%3D 15721762
-
(2005)
Nucl Med Biol
, vol.32
, Issue.2
, pp. 165-170
-
-
Cermik, T.F.1
Altiay, G.2
Firat, M.F.3
Hatipoglu, O.N.4
Berkarda, S.5
-
36
-
-
57349139105
-
Reproducibility of tumor perfusion measurements using 15O-labeled water and PET
-
10.2967/jnumed.108.053454 18927324
-
AJ de Langen M Lubberink R Boellaard MD Spreeuwenberg EF Smit OS Hoekstra, et al. 2008 Reproducibility of tumor perfusion measurements using 15O-labeled water and PET J Nucl Med 49 11 1763 1768 10.2967/jnumed.108.053454 18927324
-
(2008)
J Nucl Med
, vol.49
, Issue.11
, pp. 1763-1768
-
-
De Langen, A.J.1
Lubberink, M.2
Boellaard, R.3
Spreeuwenberg, M.D.4
Smit, E.F.5
Hoekstra, O.S.6
-
37
-
-
33744784261
-
Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients
-
10.1158/1078-0432.CCR-05-0513 1:CAS:528:DC%2BD28Xks1Ciur4%3D 16707610
-
N Gupta A Saleem B Kötz S Osman EO Aboagye R Phillips, et al. 2006 Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients Clin Cancer Res 12 10 3115 3123 10.1158/1078-0432.CCR-05-0513 1:CAS:528: DC%2BD28Xks1Ciur4%3D 16707610
-
(2006)
Clin Cancer Res
, vol.12
, Issue.10
, pp. 3115-3123
-
-
Gupta, N.1
Saleem, A.2
Kötz, B.3
Osman, S.4
Aboagye, E.O.5
Phillips, R.6
-
38
-
-
3042518844
-
Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer
-
10.1016/j.ijrobp.2003.12.014 15234030
-
K Lehtiö O Eskola T Viljanen V Oikonen T Grönroos L Sillanmäki, et al. 2004 Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer Int J Radiat Oncol Biol Phys 59 4 971 982 10.1016/j.ijrobp.2003.12.014 15234030
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.59
, Issue.4
, pp. 971-982
-
-
Lehtiö, K.1
Eskola, O.2
Viljanen, T.3
Oikonen, V.4
Grönroos, T.5
Sillanmäki, L.6
-
39
-
-
0042887593
-
Assessment of pharmacodynamic vascular response in a phase i trial of combretastatin A4 phosphate
-
10.1200/JCO.2003.05.186 1:CAS:528:DC%2BD2cXpsVKjsLc%3D 12807935
-
HL Anderson JT Yap MP Miller A Robbins T Jones P Price 2003 Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate J Clin Oncol 21 15 2823 2830 10.1200/JCO.2003.05.186 1:CAS:528:DC%2BD2cXpsVKjsLc%3D 12807935
-
(2003)
J Clin Oncol
, vol.21
, Issue.15
, pp. 2823-2830
-
-
Anderson, H.L.1
Yap, J.T.2
Miller, M.P.3
Robbins, A.4
Jones, T.5
Price, P.6
-
41
-
-
0348223970
-
Assessment of inter- and intrapatient variability in C15O2 positron emission tomography measurements of blood flow in patients with intra- abdominal cancers
-
14695134
-
P Wells T Jones P Price 2003 Assessment of inter- and intrapatient variability in C15O2 positron emission tomography measurements of blood flow in patients with intra- abdominal cancers Clin Cancer Res 9 17 6350 6356 14695134
-
(2003)
Clin Cancer Res
, vol.9
, Issue.17
, pp. 6350-6356
-
-
Wells, P.1
Jones, T.2
Price, P.3
-
42
-
-
0642376397
-
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy
-
14602864
-
D Mankoff L Dunnwald J Gralow G Ellis E Schubert J Tseng, et al. 2003 Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy J Nucl Med 44 11 1806 1814 14602864
-
(2003)
J Nucl Med
, vol.44
, Issue.11
, pp. 1806-1814
-
-
Mankoff, D.1
Dunnwald, L.2
Gralow, J.3
Ellis, G.4
Schubert, E.5
Tseng, J.6
-
43
-
-
0036218516
-
Blood flow and metabolism in locally advanced breast cancer: Relationship to response to therapy
-
11937594
-
D Mankoff L Dunnwald J Gralow G Ellis A Charlop T Lawton, et al. 2002 Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy J Nucl Med 43 4 500 509 11937594
-
(2002)
J Nucl Med
, vol.43
, Issue.4
, pp. 500-509
-
-
Mankoff, D.1
Dunnwald, L.2
Gralow, J.3
Ellis, G.4
Charlop, A.5
Lawton, T.6
-
44
-
-
0000392781
-
9:00-9:15. Antiangiogenic treatment with endostatin results in uncoupling of blood flow and glucose metabolism in human tumors
-
10.1016/S1095-0397(00)00063-7 11150754
-
N Mullani R Herbst J Abbruzzese C Charnsangavej E Kim H Tran, et al. 2000 9:00-9:15. Antiangiogenic treatment with endostatin results in uncoupling of blood flow and glucose metabolism in human tumors Clin Positron Imaging 3 4 151 10.1016/S1095-0397(00)00063-7 11150754
-
(2000)
Clin Positron Imaging
, vol.3
, Issue.4
, pp. 151
-
-
Mullani, N.1
Herbst, R.2
Abbruzzese, J.3
Charnsangavej, C.4
Kim, E.5
Tran, H.6
-
45
-
-
0000714803
-
Assessment of blood flow in solid tumors using PET
-
10.1016/S1095-0397(98)00006-5 14516600
-
L Ponto M Madsen R Hichwa N Mayr W Yuh V Magnotta, et al. 1998 Assessment of blood flow in solid tumors using PET Clin Positron Imaging 1 2 117 121 10.1016/S1095-0397(98)00006-5 14516600
-
(1998)
Clin Positron Imaging
, vol.1
, Issue.2
, pp. 117-121
-
-
Ponto, L.1
Madsen, M.2
Hichwa, R.3
Mayr, N.4
Yuh, W.5
Magnotta, V.6
-
46
-
-
0026560194
-
Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: A rapid and noninvasive dynamic method
-
1:STN:280:DyaK387nsVWrtg%3D%3D 1540969
-
C Wilson A Lammertsma C McKenzie K Sikora T Jones 1992 Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method Cancer Res 52 6 1592 1597 1:STN:280:DyaK387nsVWrtg%3D%3D 1540969
-
(1992)
Cancer Res
, vol.52
, Issue.6
, pp. 1592-1597
-
-
Wilson, C.1
Lammertsma, A.2
McKenzie, C.3
Sikora, K.4
Jones, T.5
-
47
-
-
34547846251
-
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
-
10.1038/sj.jcbfm.9600493 1:CAS:528:DC%2BD2sXptlSqtrc%3D 17519979
-
RB Innis VJ Cunningham J Delforge M Fujita A Gjedde RN Gunn, et al. 2007 Consensus nomenclature for in vivo imaging of reversibly binding radioligands J Cereb Blood Flow Metab 27 9 1533 1539 10.1038/sj.jcbfm.9600493 1:CAS:528:DC%2BD2sXptlSqtrc%3D 17519979
-
(2007)
J Cereb Blood Flow Metab
, vol.27
, Issue.9
, pp. 1533-1539
-
-
Innis, R.B.1
Cunningham, V.J.2
Delforge, J.3
Fujita, M.4
Gjedde, A.5
Gunn, R.N.6
-
48
-
-
0027390571
-
Spectral analysis of dynamic PET studies
-
1:STN:280:DyaK3s7gslahtQ%3D%3D 8417003
-
VJ Cunningham T Jones 1993 Spectral analysis of dynamic PET studies J Cereb Blood Flow Metab 13 1 15 23 1:STN:280:DyaK3s7gslahtQ%3D%3D 8417003
-
(1993)
J Cereb Blood Flow Metab
, vol.13
, Issue.1
, pp. 15-23
-
-
Cunningham, V.J.1
Jones, T.2
-
49
-
-
54049132185
-
Modelling pulmonary blood flow
-
10.1016/j.resp.2008.02.016 18434260
-
MH Tawhai KS Burrowes 2008 Modelling pulmonary blood flow Respir Physiol Neurobiol 163 1-3 150 157 10.1016/j.resp.2008.02.016 18434260
-
(2008)
Respir Physiol Neurobiol
, vol.163
, Issue.13
, pp. 150-157
-
-
Tawhai, M.H.1
Burrowes, K.S.2
-
50
-
-
77956263477
-
-
Anonymous. Analytical Methods Committee: AMC Technical Brief
-
Anonymous. Analytical Methods Committee: AMC Technical Brief. Tech. Rep.; Royal Society of Chemistry; 2003.
-
(2003)
Tech. Rep.; Royal Society of Chemistry
-
-
-
51
-
-
0031057271
-
Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET
-
1:STN:280:DyaK2s7nvVelug%3D%3D 9025761
-
U Ruotsalainen M Raitakari P Nuutila V Oikonen H Sipilä M Teräs, et al. 1997 Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET J Nucl Med 38 2 314 319 1:STN:280: DyaK2s7nvVelug%3D%3D 9025761
-
(1997)
J Nucl Med
, vol.38
, Issue.2
, pp. 314-319
-
-
Ruotsalainen, U.1
Raitakari, M.2
Nuutila, P.3
Oikonen, V.4
Sipilä, H.5
Teräs, M.6
-
52
-
-
0042887593
-
Assessment of pharmacodynamic vascular response in a phase i trial of combretastatin A4 phosphate
-
10.1200/JCO.2003.05.186 1:CAS:528:DC%2BD2cXpsVKjsLc%3D 12807935
-
HL Anderson JT Yap MP Miller A Robbins T Jones PM Price 2003 Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate J Clin Oncol 21 15 2823 2830 10.1200/JCO.2003.05.186 1:CAS:528:DC%2BD2cXpsVKjsLc%3D 12807935
-
(2003)
J Clin Oncol
, vol.21
, Issue.15
, pp. 2823-2830
-
-
Anderson, H.L.1
Yap, J.T.2
Miller, M.P.3
Robbins, A.4
Jones, T.5
Price, P.M.6
-
53
-
-
34547124062
-
Hypoxia: A key regulator of angiogenesis in cancer
-
10.1007/s10555-007-9066-y 1:CAS:528:DC%2BD2sXotFWrtLw%3D 17603752
-
D Liao RS Johnson 2007 Hypoxia: a key regulator of angiogenesis in cancer Cancer Metastasis Rev 26 2 281 290 10.1007/s10555-007-9066-y 1:CAS:528:DC%2BD2sXotFWrtLw%3D 17603752
-
(2007)
Cancer Metastasis Rev
, vol.26
, Issue.2
, pp. 281-290
-
-
Liao, D.1
Johnson, R.S.2
|